MFDS
- Marketing authorisation holder: GENZYME CORP
- Status: likely_approved
🇰🇷 Qfitlia in South Korea
Qfitlia (FITUSIRAN) regulatory status in South Korea.
Marketing authorisation
Qfitlia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Qfitlia approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Qfitlia in South Korea?
GENZYME CORP holds the South Korean marketing authorisation.